Evaluating the Long-Term Cost-Effectiveness of the English NHS Diabetes Prevention Programme using a Markov Model

被引:0
|
作者
McManus, Emma [1 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Hlth Org Policy & Econ,Div Populat Hlth Hlth Serv, Suite 12,Floor 7,Williamson Bldg,Oxford Rd, Manchester M13 9PL, England
关键词
LIFE-STYLE INTERVENTION; UNITED-KINGDOM; RISK; CARE; METFORMIN; ADULTS; IDENTIFICATION; STRATEGIES; MELLITUS; PEOPLE;
D O I
10.1007/s41669-024-00487-6
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background In 2016, England launched the largest nationwide diabetes mellitus prevention programme, the NHS Diabetes Prevention Programme (NHS DPP). This paper seeks to evaluate the long-term cost-effectiveness of this programme.Methods A Markov cohort state transition model was developed with a 35-year time horizon and yearly cycles to compare referral to the NHS DPP to usual care for individuals with non-diabetic hyperglycaemia. The modelled cohort of individuals mirrored the age profile of referrals received by the programme by April 2020. A health system perspective was taken, with costs in UK pound Sterling (price year 2020) and outcomes in terms of quality-adjusted life-years (QALYs). Probabilistic analysis with 10,000 Monte Carlo simulations was used. Several sensitivity analyses were conducted to explore the uncertainty surrounding the base case results, particularly varying the length of time for which the effectiveness of the programme was expected to last.Results In the base case, using only the observed effectiveness of the NHS DPP at 3 years, it was found that the programme is likely to dominate usual care, by generating on average 40.8 incremental QALYs whilst saving 135,755 pound in costs for a cohort of 1000. At a willingness to pay of 20,000 pound per QALY, 98.1% of simulations were on or under the willingness-to-pay threshold. Scaling this up to the number of referrals actually received by the NHS DPP prior to April 2020, cost savings of 71.4 pound million were estimated over the 35-year time horizon and an additional 21,472 QALYs generated. These results are robust to several sensitivity analyses.Conclusion The NHS DPP is likely to be cost-effective. Indeed, in the majority of the simulations, the NHS DPP was cost-saving and generated greater QALYs, dominating usual care. This research should serve as evidence to support the continued investment or recommissioning of diabetes prevention programmes.
引用
收藏
页码:569 / 583
页数:15
相关论文
共 50 条
  • [1] Cost and clinical implications of diabetes prevention in an Australian setting: A long-term modeling analysis
    Palmer, A. J.
    Tucker, D. M. D.
    PRIMARY CARE DIABETES, 2012, 6 (02) : 109 - 121
  • [2] Long-term cost-effectiveness of a Patient Empowerment Programme for type 2 diabetes mellitus in primary care
    Lian, Jinxiao
    McGhee, Sarah M.
    So, Ching
    Chau, June
    Wong, Carlos K. H.
    Wong, William C. W.
    Lam, Cindy L. K.
    DIABETES OBESITY & METABOLISM, 2019, 21 (01) : 73 - 83
  • [3] Long-term cost-effectiveness of health behaviour intervention to manage type 2 diabetes in Nepal
    Dahal, Padam Kanta
    Vandelanotte, Corneel
    Rawal, Lal
    Mahumud, Rashidul Alam
    Paudel, Grish
    Lloyd, Melanie
    Baek, Yeji
    Karmacharya, Biraj
    Sugishita, Tomohiko
    Ademi, Zanfina
    BMC MEDICINE, 2025, 23 (01):
  • [4] EVALUATING COST-EFFECTIVENESS OF TREATMENT OPTIONS FOR DIABETES PATIENTS USING SYSTEM DYNAMICS MODELING
    Liu, Shiyong
    Xu, Judy C.
    Liu, Gordon
    Xue, Hong
    Bishai, David
    Wang, Youfa
    2018 WINTER SIMULATION CONFERENCE (WSC), 2018, : 2577 - 2588
  • [5] Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
    Hoogendoorn, Martine
    Feenstra, Talitha L.
    Hoogenveen, Rudolf T.
    Rutten-van Molken, Maureen P. M. H.
    THORAX, 2010, 65 (08) : 711 - 718
  • [6] Response to "Comment on 'Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program'"
    Wimo, Anders
    Handels, Ron
    Antikainen, Riitta
    Eriksdotter, Maria
    Jonsson, Linus
    Knapp, Martin
    Kulmala, Jenni
    Laatikainen, Tiina
    Lehtisalo, Jenni
    Peltonen, Markku
    Skoldunger, Anders
    Soininen, Hilkka
    Solomon, Alina
    Strandberg T, Timo
    Tuomilehto, Jaakko
    Ngandu, Tiia
    Kivipelto, Miia
    ALZHEIMERS & DEMENTIA, 2023, 19 (10) : 4760 - 4763
  • [7] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Permsuwan, Unchalee
    Chaiyakunapruk, Nathorn
    Dilokthornsakul, Piyameth
    Thavorn, Kednapa
    Saokaew, Surasak
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2016, 14 (03) : 281 - 292
  • [8] Cost-effectiveness analysis of a digital diabetes-prevention programme versus an in-person diabetes-prevention programme in people with prediabetes in the United States
    Park, Sooyeol
    Ballreich, Jeromie
    Ward, Trevor
    Shi, Lizheng
    DIABETES OBESITY & METABOLISM, 2024, 26 (10) : 4522 - 4534
  • [9] Cost-Effectiveness of the Tailored Activity Programme for Person With Dementia-Caregiver Dyads: A Markov Model
    Gannon, Brenda
    Vo, Vinh
    Gitlin, Laura N.
    Bennett, Sally
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2025, 40 (02)
  • [10] A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support
    Nunes, Abraham J.
    MacArthur, Roderick G. G.
    Kim, Daniel
    Singh, Gurmeet
    Buchholz, Holger
    Chatterley, Patricia
    Klarenbach, Scott W.
    VALUE IN HEALTH, 2016, 19 (04) : 494 - 504